Navigation Links
Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer - International White Paper Launched at European Cancer Congress 2013
Date:9/28/2013

AMSTERDAM, Sept. 28, 2013 /PRNewswire/ -- The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer (mCRC), the third most common cancer among men and the second most common among women worldwide. The white paper, "Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer," is the result of the International Expert Summit for mCRC, convened by the Angiogenesis Foundation in Berlin, Germany, this past July, that gathered a global multidisciplinary group of leading experts on the field.

New targeted drugs that have been approved since 2004 have shifted oncologists' approach to treating mCRC, and the standard of care now involves treatments aimed at interfering with angiogenesis—new blood vessel growth—which supplies tumors with oxygen and nutrients. Antiangiogenic treatments have increased both the survival and quality of life for patients suffering from this disease. 

"With the advent of antiangiogenic therapy, metastatic CRC can now be approached as a cancer with multiple treatment options over time— choices that can improve a patient's quality of life. However, the benefit of these treatments has yet to be maximized and optimal care needs to be more accessible to all patients," commented Dr. William Li, President and Medical Director of the Angiogenesis Foundation.

This white paper addresses the current state of the field, identifies future goals and the barriers to those goals, and makes recommendations for advocacy leaders, oncologists, and the cancer community at large for improving patient outcomes worldwide. The white paper is being distributed at the European Cancer Congress at the Angiogenesis Foundation's advocacy booth, and can be downloaded at www.scienceofcrc.org/mCRC-globalwhitepaper.

The Angiogenesis Foundation (www.angio.org) is a nonprofit organization based in Cambridge, MA, USA that works with multiple stakeholders and leads international programs to improve health through treatments based on angiogenesis, the process of new blood vessel growth.


'/>"/>
SOURCE The Angiogenesis Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. 9th EUGMS Congress in Venice, Italy: Improving Outcomes of Geriatric Medicine
2. Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes
3. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
4. B. Braun Committed To Improving Patient Safety
5. New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes
6. Treatment Adherence Emerging as Critical Theme in Improving Quality and Cost of US Healthcare
7. Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
8. Oncologists in the United States and Europe Indicate that Novel Chemotherapies Hold the Most Near-Term Promise for Improving Outcomes in Soft Tissue Sarcoma
9. Biometrics Limits Abuse while Improving Convenience
10. GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities
11. Mt. Airy Hospital Selects Sound Physicians - Leading Hospitalist Organization Focuses on Improving Quality and Reducing Cost of Inpatient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... 2017  As the latest Obamacare repeal effort moves ... (R-LA) and Lindsey Graham (R-SC) medical ... device industry is in an odd place.  The industry ... excise tax on medical device sales passed along with ... patients, increased visits and hospital customers with the funding ...
(Date:9/19/2017)... ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device ... precise destruction of targeted tissues, announced three leadership team developments today:   ... Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... 12, 2017 , ... Asante, a nationally recognized health system ... their existing home health joint venture through an agreement, effective October 1, 2017, ... venture home health company with Asante, delivering clinically integrated care, for the past ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):